|
|
|
|
|
|
|
|
|
|
Super Quote | Detail Quote | Interactive Chart | Transaction | Related News | Related Securities | Company Information | Dividend Records | Short Sell
00775 CKLIFE SCIENCES
Nominal 
0.450 -0.005 (-1.099%) | 2024/06 - Interim HKD(K$) | 2023/12 HKD(K$) | 2022/12 HKD(K$) | 2021/12 HKD(K$) | 2020/12 HKD(K$) | |
| Net Cash from / (used in) Operating Activities | -- | 514,181 | 363,659 | 423,575 | 530,955 |
| Net Cash from / (used in) Investing Activities | -- | (67,961) | (22,119) | (257,884) | (457,312) |
| Net Cash from / (used in) Financing Activities | -- | (477,953) | (515,340) | (220,081) | 168,742 |
| Increase / (Decrease) in Cash & Cash Equivalents | -- | (31,733) | (173,800) | (54,390) | 242,385 |
| Cash & Cash Equivalents at beginning of period | -- | 691,934 | 890,801 | 958,998 | 696,504 |
| Effect of Foreign Exchange Rate Changes | -- | 4,119 | (25,067) | (13,807) | 20,109 |
| Others | -- | 0 | 0 | 0 | 0 |
| Cash & Cash Equivalents at end of period | -- | 664,320 | 691,934 | 890,801 | 958,998 |
| Remarks: | Real time quote last updated: 15/11/2024 17:59 |
| Real-time basic market prices of Hong Kong securities are provided by HKEx; a Designated Website authorized by the HKEx Group to provide the Service | |
| Profit / (Loss) Attributable to Shareholders (K$) | HKD 1,001 |
| %Change | -97.288% |
| EPS / (LPS) | HKD 0.000 |
| NBV Per Share ($) | HKD 0.418 |